Platelet Transfusion
Publication Date: November 28, 2017
Key Points
Key Points
- Prophylactic platelet transfusion should be administered to patients with thrombocytopenia resulting from impaired bone marrow function to reduce the risk of hemorrhage when the platelet count falls below a predefined threshold level.
- Recommended thresholds for prophylactic platelet transfusion are provided for patients with hematologic malignacies or solid tumors, and those undergoing hematopoietic stem cell transplantation or invasive procedures.
- Guidance is also provided regarding the production of platelet products, prevention of Rh alloimmunization, and management of refractoriness to platelet transfusion.
Treatment
...eatmen...
...ation of Platelet ProductsPlatelets for tran...
...evention of Rh AlloimmunizationUPDATED. Preventi...
...eukoreductionUPDATED. The incidence of...
...phylactic vs Therapeutic Platelet Trans...
...ansfusion Threshold in Patients wit...
...atelet Transfusion Threshold in the...
...usion in Patients with Chronic, Stable...
...let Transfusion Threshold in Patients With So...
...t Count at which Surgical or Invasive...
...for Refractoriness to Platelet TransfusionUPDATE...
...ing Refractoriness to Platelet TransfusionAlloim...